Gene · 4440
Papers1,911
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 1,911
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The transcript ENST00000444125 of lncRNA LINC01503 promotes cancer stem cell properties of glioblastoma cells via reducing FBXW1 mediated GLI2 degradation. | Exp Cell Res | 2022 | 34990616 | PubTator, text mining | PubMed |
| Mechanism of RNA recognition by a Musashi RNA-binding protein. | Curr Res Struct Biol | 2022 | 34988468 | PubTator, text mining | PubMed |
| Research progress on the hedgehog signalling pathway in regulating bone formation and homeostasis. | Cell Prolif | 2022 | 34918401 | PubTator, text mining | PubMed |
| Delivery of CRISPR-Cas9 system for screening and editing RNA binding proteins in cancer. | Adv Drug Deliv Rev | 2022 | 34767864 | PubTator, text mining | PubMed |
| Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring. | Clin Cancer Res | 2022 | 34615723 | PubTator, text mining | PubMed |
| Circ_KIAA1199 inhibits MSI1 degradation by targeting miR-34c-5p to drive the malignant cell behaviors and tumor growth of colorectal cancer. | Anticancer Drugs | 2022 | 34387591 | PubTator, text mining | PubMed |
| Spelling Out CICs: A Multi-Organ Examination of the Contributions of Cancer Initiating Cells' Role in Tumor Progression. | Stem Cell Rev Rep | 2022 | 34244971 | PubTator, text mining | PubMed |
| Systematic Genome-Wide Profiles Reveal Alternative Splicing Landscape and Implications of Splicing Regulator DExD-Box Helicase 21 in Aggressive Progression of Adrenocortical Carcinoma. | Phenomics | 2021 | 36939770 | PubTator, text mining | PubMed |
| Identification and expression of phospholipase A2 genes related to transcriptional control in the interleukin-17A/F1 pathway in the intestines of Japanese medaka Oryzias latipes. | Fish Shellfish Immunol Rep | 2021 | 36420487 | PubTator, text mining | PubMed |
| Regulation of cancer stem cells in triple negative breast cancer. | Cancer Drug Resist | 2021 | 35582030 | PubTator, text mining | PubMed |
| Evasion of Host Antiviral Innate Immunity by Paramyxovirus Accessory Proteins. | Front Microbiol | 2021 | 35173691 | PubTator, text mining | PubMed |
| Interaction of ncRNA and Epigenetic Modifications in Gastric Cancer: Focus on Histone Modification. | Front Oncol | 2021 | 35155211 | PubTator, text mining | PubMed |
| A System Bioinformatics Approach Predicts the Molecular Mechanism Underlying the Course of Action of Radix Salviae Reverses GBM Effects. | Evid Based Complement Alternat Med | 2021 | 35154340 | PubTator, text mining | PubMed |
| Small Molecule Palmatine Targeting Musashi-2 in Colorectal Cancer. | Front Pharmacol | 2021 | 35153752 | PubTator, text mining | PubMed |
| A bioinformatics analysis to evaluate the prognostic value of stemness-related genes in gastric cancer. | Transl Cancer Res | 2021 | 35116249 | PubTator, text mining | PubMed |
| Identification of Bovine miRNAs with the Potential to Affect Human Gene Expression. | Front Genet | 2021 | 35087564 | PubTator, text mining | PubMed |
| Evolution of the Neocortex Through RNA-Binding Proteins and Post-transcriptional Regulation. | Front Neurosci | 2021 | 35082597 | PubTator, text mining | PubMed |
| miR-671-5p Inhibition by MSI1 Promotes Glioblastoma Tumorigenesis via Radioresistance, Tumor Motility and Cancer Stem-like Cell Properties. | Biomedicines | 2021 | 35052701 | PubTator, text mining | PubMed |
| A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma. | Medicine (Baltimore) | 2021 | 35049227 | PubTator, text mining | PubMed |
| The RNA-Binding Protein Musashi1 Regulates a Network of Cell Cycle Genes in Group 4 Medulloblastoma. | Cells | 2021 | 35011618 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4440/papers?page=21